DAPANOVA L 10mg/5mg Tablet is an advanced antidiabetic medicine designed for adults with type two diabetes mellitus. It is a dual combination of Dapagliflozin and Linagliptin, formulated to provide comprehensive blood sugar control. Dapagliflozin, an SGLT2 inhibitor, lowers blood glucose by promoting the excretion of excess sugar through urine, while Linagliptin, a DPP-4 inhibitor, enhances insulin secretion and reduces glucagon release, helping to control post-meal and fasting blood sugar levels. This combination supports stable blood sugar throughout the day, reduces the risk of diabetes-related complications such as kidney damage, heart disease, nerve issues, and eye disorders, and improves overall energy and wellbeing. When combined with a balanced diet, regular physical activity, and proper lifestyle measures, DAPANOVA L 10mg/5mg Tablet helps patients achieve better glycemic control and long-term diabetes management.

Benefits

Provides dual action for effective blood sugar management
Lowers both fasting and post-meal glucose levels
Improves insulin secretion from pancreatic cells
Reduces glucagon release to prevent sugar spikes
Promotes natural elimination of glucose through urine
Helps lower HbA1c levels effectively
Improves energy and reduces fatigue
Supports kidney health and reduces risk of complications
Reduces burden on pancreatic beta cells
Enhances overall sugar utilization in tissues
Supports weight management in some patients
Provides stable blood sugar control throughout the day
Complements lifestyle measures like diet and exercise
Reduces risk of cardiovascular complications
Helps prevent long-term diabetes-related issues

Possible Side Effects

Nausea or mild stomach upset in some patients
Diarrhea or abdominal discomfort
Increased urination due to sugar elimination
Headache or dizziness in certain individuals
Genital or urinary tract infections may occur
Rare hypoglycemia when combined with other medicines
Metallic taste in the mouth occasionally
Mild rash or skin irritation in some patients
Fatigue or weakness reported rarely
Dehydration if fluid intake is low

How to Use

Take orally with or without food as prescribed
Swallow the tablet whole with a glass of water
Take at the same time every day for best results
Do not skip or double doses unnecessarily
Continue following diet and exercise plan
Use strictly under medical supervision

How it Works

Dapagliflozin promotes glucose excretion through urine
Linagliptin increases insulin secretion and reduces glucagon
Dual mechanism provides better blood sugar control
Improves insulin sensitivity in body tissues
Maintains stable glucose levels throughout the day

What to Avoid

Avoid alcohol consumption
Do not skip meals after taking the tablet
Avoid self-adjusting the dose
Do not use other antidiabetic drugs unless prescribed
Avoid sugary and refined foods
Do not take expired tablets
Avoid dehydration by drinking enough water
Refrain from smoking as it worsens complications
Do not drive if feeling dizzy or weak
Avoid heavy physical exertion when sugar levels are low

Safety Advice

Follow doctor’s instructions carefully
Monitor blood sugar regularly
Stay hydrated to prevent dehydration
Inform doctor about all ongoing medications
Report any frequent urinary infections
Inform physician before surgery or tests
Pregnant or breastfeeding women should consult doctor
Elderly patients should use cautiously
Maintain a balanced, fiber-rich diet
Engage in regular physical activity

Precautions

Not suitable for type one diabetes
Avoid in diabetic ketoacidosis
Use cautiously in patients with kidney or liver disorders
Patients prone to urinary infections should be careful
Not recommended for children unless prescribed
Elderly patients should be monitored closely
Avoid alcohol to reduce risk of complications
Do not drive if experiencing dizziness
Always carry sugar source for hypoglycemia
Seek immediate medical help in case of severe infection